Answers are grounded in this paper and cite their sources.
Remove to improve. Removal of the hydroxymethyl groups in 1 to give 2 significantly enhances inhibitory potency towards glucosylceramide β-glucosidase (GCase) and abolishes inhibition towards α-glucosidases. Xylitol 2 doubles the residual activity of GCase in fibroblasts from Gaucher patients at subinhibitory concentration (10 nM). This compound is therefore a promising candidate for the development of small-molecule drugs for the treatment of Gaucher's disease without the side effects associated with α-glucosidase inhibition.
No takes yet. Share an insight, caveat, or question.
Compain et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: